Saryah Azmat
Corporate Officer/Principal presso TURNSTONE BIOLOGICS CORP.
Patrimonio netto: - $ in data 31/05/2024
Provenienza dei contatti di primo grado di Saryah Azmat
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Saryah Azmat tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
I5 Surviving Corp.
 I5 Surviving Corp. Medical/Nursing ServicesHealth Services Inception 5, Inc. develops and researches novel small molecule demyelinating therapies for patients with multiple sclerosis. The company is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
| CARIBOU BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| Texas A&M University | College/University | Graduate Degree | |
| Pepperdine University | College/University | Undergraduate Degree | |
| University of Bristol | College/University | Doctorate Degree | |
| University of Madras | College/University | Undergraduate Degree | |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Columbia University Medical Center | College/University | Corporate Officer/Principal | |
| The Royal College of Paediatrics & Child Health | College/University | Corporate Officer/Principal | |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Director/Board Member | |
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Versant Ventures VI GP-GP LLC | Corporate Officer/Principal | ||
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member | |
Versant Venture Capital VI (Canada) LP
 Versant Venture Capital VI (Canada) LP Investment ManagersFinance Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA. | Investment Managers | Director/Board Member | |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
| Versant Ventures Canada Ltd. | Investment Managers | Private Equity Investor | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
| IN8BIO, INC. | Biotechnology | Director of Finance/CFO | |
| Versant Ventures VII GP-GP LLC | Corporate Officer/Principal | ||
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Northern Mosaic LP
 Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Chinook Therapeutics U.S., Inc.
 Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | Information Technology Services | Director/Board Member | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Chairman | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Tentarix Biotherapeutics LP
 Tentarix Biotherapeutics LP BiotechnologyHealth Technology Tentarix Biotherapeutics LP operates as a biotechnology company. The company is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
| CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
BlueRock Therapeutics LP
 BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
| Tentarix Biotherapeutics, Inc. | Director/Board Member | ||
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Director/Board Member | |
Myst Therapeutics LLC
 Myst Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Myst Therapeutics LLC is a privately held, pre-clinical stage biotechnology company based in Glendale, CA. Myst Therapeutics LLC focuses on the development and commercialization of novel cancer immunotherapy products that utilize a patient's own immune system to treat solid tumors. Myst is dedicated to improving adoptive cell therapies, particularly neoantigen enriched T cell therapies for solid tumors. By combining methods of identifying neoantigen reactive T cells with their proprietary technologies and expertise in cell therapy development and manufacturing, Myst aims to rapidly advance and commercialize innovative therapies for a wide range of advanced solid tumors. The CEO of the company is Sammy J. Farah. Myst Therapeutics was acquired by Turnstone Biologics, Inc. on January 20, 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
| METAGENOMI, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 35 |
| Canada | 10 |
| Regno Unito | 5 |
| India | 2 |
| Germania | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Finance | 4 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 90 |
| Independent Dir/Board Member | 29 |
| Corporate Officer/Principal | 25 |
| Chief Tech/Sci/R&D Officer | 14 |
| Director of Finance/CFO | 10 |
Contatti più connessi
| Insiders | |
|---|---|
| Clarence Machado | 30 |
| Rishi Gupta | 29 |
| Jerel Davis | 29 |
| Santhosh Palani | 14 |
| Robert Gould | 12 |
| Michael Burgess | 12 |
| Kanya Rajangam | 11 |
| Sammy Farah | 9 |
| Stewart Abbot | 9 |
| P. Campisi | 6 |
| Patrick McCall | 5 |
| Vijay Chiruvolu | 5 |
| Venkat Ramanan | 1 |
| Ahmed Aneizi | 1 |
- Borsa valori
- Insiders
- Saryah Azmat
- Connessioni Società
